Center Laboratories, Inc. (TPEX:4123)
38.25
+0.45 (1.19%)
May 29, 2026, 1:30 PM CST
Center Laboratories Revenue
Center Laboratories had revenue of 465.98M TWD in the quarter ending March 31, 2026, with 22.99% growth. This brings the company's revenue in the last twelve months to 1.60B, down -1.84% year-over-year. In the year 2025, Center Laboratories had annual revenue of 1.52B, down -6.28%.
Revenue (ttm)
1.60B
Revenue Growth
-1.84%
P/S Ratio
17.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.52B | -101.68M | -6.28% |
| Dec 31, 2024 | 1.62B | 223.86M | 16.06% |
| Dec 31, 2023 | 1.39B | 626.29M | 81.58% |
| Dec 31, 2022 | 767.72M | 267.62M | 53.51% |
| Dec 31, 2021 | 500.11M | -216.94M | -30.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 24.42B |
| Bora Pharmaceuticals | 18.54B |
| Grape King Bio | 10.28B |
| YungShin Global Holding | 8.04B |
| Standard Chemical & Pharmaceutical | 7.03B |
| TTY Biopharm Company | 6.51B |
| Synmosa Biopharma | 6.37B |
| ScinoPharm Taiwan | 3.14B |